Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $170

Credit Suisse analyst Matt Miksic maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and raises the price target from $163 to $170.

Benzinga · 01/27/2020 12:27

Credit Suisse analyst Matt Miksic maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and raises the price target from $163 to $170.